Pancreatic Cancer Research

ReviewJ Gastrointest Oncol2022

Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review.

Journal
J Gastrointest Oncol
Published
1 April 2022
Citations
2
Type
Review

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background and objective Borderline resectable pancreatic cancer (BRPC) is a tumor that infiltrates into the large blood vessels, with a high probability that the tumor will remain after surgical resection. To date, there has been no confirmed treatment strategy for BRPC. … Excerpt only: this text is the publisher’s. Read it in full at the source.